What it is
Reduced smell / hyposmia describes partial or complete loss of olfactory ability from viral illness, neurological causes, or post-COVID sequelae.
Emerging evidence
Reduced Smell
Partial or complete reduction in the ability to detect odours, which may be temporary or persistent depending on the underlying cause.
CategoryNeurological
Reviewed by Gyfts Editorial Team · Editorial Health Review
26 March 2026
At a glance
Reduced Smell at a glance
Commonly experienced as
- Food tasting bland, inability to detect pleasant or warning odours, and reduced food enjoyment. Some describe phantom smells (parosmia) — distorted or unpleasant odour perceptions.
Evidence context
Emerging evidenceSee the evidence snapshotSafety
See staying safeContext
Patterns of Reduced Smell
Reduced smell — hyposmia (partial) or anosmia (complete absence) — describes a diminished or absent ability to detect olfactory stimuli. The olfactory system is anatomically distinct from other sensory systems, with direct projections from the olfactory epithelium through the cribriform plate to the olfactory bulb and cortex, making it uniquely susceptible to upper respiratory viral infection and neurodegeneration. Common causes include: acute viral upper respiratory infection (the most frequent cause, typically transient), post-COVID-19 olfactory dysfunction (which may persist for months or become permanent), nasal polyps or chronic sinusitis (obstructive), head trauma damaging the olfactory nerve fibres, and neurodegeneration (loss of smell is an early, often pre-motor marker of Parkinson's disease and Lewy body dementia). Parosmia (distorted smell) and phantosmia (phantom smells) are related conditions frequently co-occurring after viral illness.
Could this be you
People commonly experience
Reduced Smell shows up differently for everyone. Browse by how it tends to be felt — these are common experiences, not a checklist or a diagnosis.
In daily life1 common experience
- Food tasting bland, inability to detect pleasant or warning odours, and reduced food enjoyment. Some describe phantom smells (parosmia) — distorted or unpleasant odour perceptions.
Common experiences people describe — not a diagnostic checklist.
The Evidence
Evidence context
What research and clinical practice currently suggest about reduced smell — its causes, recovery options, and when professional assessment is essential.
Overall pictureModerate evidence
Smell loss is well-characterised; recovery support has growing evidence
Reduced smell has clearly identified causes and a growing evidence base for structured recovery approaches, particularly olfactory training after viral illness. Some causes require prompt professional assessment and should not be managed independently.
When to seek urgent assessmentSeveral presentations of smell loss require prompt professional evaluation and should not be self-managed.
Sudden smell loss with facial pain, weakness, or visual changes may indicate a neurological emergency. Unilateral loss with blood-stained nasal discharge warrants assessment for intranasal pathology. New smell loss in an older adult with gait changes or tremor may be an early marker of Parkinson's disease. Post-COVID anosmia persisting beyond three months warrants specialist referral.
What the evidence supportsOlfactory training has the strongest evidence base for post-viral smell recovery.
Structured olfactory training — repeated, deliberate exposure to strong odorants such as rose, eucalyptus, lemon, and clove — has moderate to strong evidence for post-viral and post-COVID recovery. Intranasal corticosteroids are supported for inflammatory or polyp-related causes. Alpha-lipoic acid has limited evidence in post-viral cases. Zinc supplementation evidence is mixed; high-dose use carries risk of copper deficiency.
Understanding the causesSmell loss has multiple distinct causes, each with different implications for recovery and management.
The most common cause is acute viral upper respiratory infection, usually transient. Post-COVID olfactory dysfunction may persist for months or become permanent. Nasal polyps and chronic sinusitis cause obstructive loss. Head trauma can damage olfactory nerve fibres. Importantly, smell loss is a recognised early marker of neurodegeneration, including Parkinson's disease and Lewy body dementia, often preceding motor symptoms.
Complementary approaches in contextSome complementary approaches are used alongside conventional care for smell recovery, with varying evidence.
Olfactory training protocols, while evidence-based, are often delivered outside clinical settings and may be supported by aromatherapy practitioners. Traditional Chinese Medicine and Ayurvedic Nasya therapy are used for nasal and sensory pathway support, though clinical evidence for these specifically in anosmia is limited. These approaches are best considered alongside, not instead of, professional assessment where indicated.
Safety considerationsA few practical safety points apply when exploring self-managed approaches to smell loss.
Long-term use of nasal decongestants is not recommended — rebound congestion may worsen olfactory symptoms. High-dose zinc supplementation can cause copper deficiency and should remain within therapeutic ranges. Any approach that delays professional assessment for a potentially serious underlying cause carries its own risk. Self-managed strategies are most appropriate for confirmed post-viral recovery contexts.
When professional input adds most valueProfessional assessment helps identify the cause and guides the most appropriate recovery pathway.
A GP or ENT specialist can assess whether smell loss is obstructive, post-viral, medication-related, or neurological — each requiring a different approach. Persistent post-COVID anosmia beyond three months warrants specialist review. Neurological causes require assessment by a neurologist. Self-directed olfactory training is reasonable for confirmed post-viral cases, but professional input ensures the underlying cause is not missed.
Safety first
Staying safe
General, informational guidance — not diagnostic. A qualified practitioner can advise on your own situation.
- Avoid nasal decongestants long-term — rebound congestion may compound olfactory symptoms
- High-dose zinc supplementation may cause copper deficiency — use within therapeutic ranges
References
Evidence & Research
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
- Central sensitization: Implications for the diagnosis and treatment of pain
- Principles of neural science (5th ed.)
- Harrison's neurology in clinical medicine (3rd ed.)
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Find Reduced Smell practitioners you can trust
Browse practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.